This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2002-2007.
Company Filing History:
Years Active: 2002-2007
Title: The Innovations of Daniel A Ventura
Introduction
Daniel A Ventura is an accomplished inventor based in Galveston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide aptamers. With a total of 2 patents to his name, Ventura's work has garnered attention for its innovative approaches and practical applications.
Latest Patents
Ventura's latest patents focus on the combinatorial selection of oligonucleotide aptamers. This random combinatorial selection method is designed to construct oligonucleotide aptamers that exhibit nuclease resistance through the incorporation of modified nucleotides. These modified nucleotides are integrated during PCR amplification, resulting in achiral modified oligonucleotides. Notably, thio-substituted aptamers are developed that bind tightly to the nuclear factor for human IL6 (NF-IL6). This advancement has the potential to impact various therapeutic applications.
Career Highlights
Daniel A Ventura is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His work not only contributes to the academic community but also has implications for real-world applications in medicine and biotechnology. Ventura's innovative spirit and dedication to research have established him as a notable figure in his field.
Collaborations
Throughout his career, Ventura has collaborated with esteemed colleagues, including David J King and Allan R Brasier. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research endeavors.
Conclusion
Daniel A Ventura's contributions to the field of biotechnology through his patents and research at the University of Texas System highlight his role as an influential inventor. His work on oligonucleotide aptamers showcases the potential for innovation in therapeutic applications.
